This study also confirms the ability of the ICES database to be a reliable source at a population level for examining the outcomes of patients diagnosed with lung cancer and administered ALK TKIs in Ontario due to its strong connectivity to multiple data sources and the completeness of the data variables within it. This evidence concerns the gene ALK and lung cancer.